NCT03732131 The Finnish Faecal Microbiota Transplantation Study (FINFMT)
| NCT ID | NCT03732131 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Joint Authority for Päijät-Häme Social and Health Care |
| Condition | Faecal Microbiota Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-10-18 |
| Primary Completion | 2021-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2018-10-18 with a primary completion date of 2021-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.
Eligibility Criteria
Inclusion Criteria: * \> 18 years age * receiving FMT for rCDI or any other madical condition * written consent * Not included in other FMT trials Exclusion Criteria: * Unable to provide written consent * \< 18 years age * Included in other FMT-trial
Contact & Investigator
Perttu Arkkila, PhD
STUDY DIRECTOR
Head of Department
Frequently Asked Questions
Who can join the NCT03732131 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Faecal Microbiota Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03732131 currently recruiting?
Yes, NCT03732131 is actively recruiting participants. Contact the research team at perttu.lahtinen@phhyky.fi for enrollment information.
Where is the NCT03732131 trial being conducted?
This trial is being conducted at Lahti, Finland.
Who is sponsoring the NCT03732131 clinical trial?
NCT03732131 is sponsored by Joint Authority for Päijät-Häme Social and Health Care. The principal investigator is Perttu Arkkila, PhD at Head of Department. The trial plans to enroll 200 participants.